Engineering the Human Fc Region Enables Direct Cell Killing by Cancer Glycan-Targeting Antibodies without the Need for Immune Effector Cells or Complement. (2020)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-19-3599

PubMed Identifier: 32532823

Publication URI: http://europepmc.org/abstract/MED/32532823

Type: Journal Article/Review

Volume: 80

Parent Publication: Cancer research

Issue: 16

ISSN: 0008-5472